- CLINICAL INSTRUCTOR | Ophthalmology
- Hospital Affiliation
- The Mount Sinai Hospital
While at Harvard, Dr. Kornstein participated in clinical laser vision studies preceding the FDA approval of the excimer laser. He has extensive experience in "bladeless" LASIK with the Intralase laser and has served as an Intralase instructor for other physicians. Dr. Kornstein was the first surgeon in the New York area to combine Intralase with Intacs corneal inserts for treating keratoconus.
Dr. Kornstein is a Diplomate of the American Academy of Ophthalmology and a member of the American Society of Cataract and Refractive Surgery, the International Society of Refractive Surgery, the New York Keratorefractive Society, the New York Intraocular Lens Implant Society and the Medical Society of the State of New York.
MD, Brown University
Residency, Internal Medicine
Mount Auburn Hospital
Bellevue Hospital Center
North Shore University Hospital at Manhasset
Kakaria SK, Kornstein HS. Visual Acuities and Manifest Refractions Prior to LASIK Retreatments. Journal of Refractive Surgery 2006; 22: 200-202.
Perry HD, Doshi-Carnevale S, Donnenfeld ED, Kornstein HS. Topical Cyclosporine A 0.5% as a Possible New Treatment for Superior Limbic Keratoconjunctivitis. Ophthalmology 2003; 110: 1578-1581.
Donnenfeld ED, Kornstein HS, Amin A. LASIK for the Correction of Myopia and Astigmatism Following Penetrating Keratoplasty. Ophthalmology 1999; 106: 1966-1975.
Talamo JH, Kornstein HS. Pavan-Langston D, editor. Manual of Ocular Diagnosis and Therapy. 4th ed.. Boston, Little, Brown and Company;.
Kornstein HS, Filatov V, Talamo JH. Objective and Subjective Analysis Following Excimer Photorefractive Keratectomy for Moderate Myopia [abstract]. Investigative Ophthalmology and Visual Science. 1996; 37:. Abstract S573.
Kornstein HS, Filatov V, Talamo JH. The Influence of Age on One Year Results of Excimer Photorefractive Keratectomy for Moderate Myopia [abstract]. Investigative Ophthalmology and Visual Science. 1995; 36:. Abstract S983.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Kornstein is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.